Clinical Trial Update: Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates whether acetazolamide, mannitol, and N-acetylcysteine can mitigate cisplatin-induced nephrotoxicity. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cisplatin-induced Nephrotoxicity

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Mannitol (mannitol)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Cisplatin Nephrotoxicity | Phase 2 | Status: COMPLETED